Target intelligence / Profile preview

DnaJ heat shock protein family (Hsp40) member C28 (DNAJC28)

Target
DNAJC28
Molecular classification
Heat shock protein, Molecular chaperone, Other
01

Overview

DnaJ heat shock protein family (Hsp40) member C28 (DNAJC28) is a protein-coding gene located on chromosome 21, encoding a 388-amino-acid protein that functions as a member of the DnaJ (Hsp40) co-chaperone family[2][3][5][6]. The protein contains a conserved N-terminal J-domain, essential for interaction with Hsp70 chaperones involved in ATPase regulation and protein folding[2][3][10]. DNAJC28 is thought to facilitate proper folding of newly synthesized proteins, act as a molecular chaperone to prevent aggregation, contribute to protein quality control, and participate in vesicle transport processes within the Golgi[1][2][7]. There is no current evidence that DNAJC28 itself is a therapeutic target; it is classified as a molecular chaperone, not a receptor, enzyme, transporter, or traditional drug target[3][6][11]. Disease associations are not well defined, though variants have been annotated with rare neuronopathy phenotypes[3]. There are no known drugs targeting DNAJC28, and no established biomarker or safety concerns linked specifically to this gene[3][10][12].

Other names
C21orf55C21orf78DnaJ homolog subfamily C member 28Orf28DJC28DJC28_HUMAN
02

Biological functions

Protein foldingMolecular chaperone activityProtein quality controlRetrograde transport and vesicle recycling within GolgiCellular protein homeostasis
03

Disease associations

Distal hereditary motor neuronopathy (limited evidence)Other

Beyond the preview

Go deeper on DnaJ heat shock protein family (Hsp40) member C28 (DNAJC28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DnaJ heat shock protein family (Hsp40) member C28 (DNAJC28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call